Order Entry
Switzerland
ContactUsLinkComponent
Human recombinant Cyclin-Dependent Kinase 2 (from E. coli)
Human recombinant Cyclin-Dependent Kinase 2 (from E. coli)
  PRSI91-191
 :  
Human recombinant Cyclin-Dependent Kinase 2 (from E. coli)
  PRSI91-191
 :  

 

  • Pk:
    50 µG
  • Enzyme type:
    Recombinant
  • Source:
    E. coli
  • Species:
    Human
  • Tag sequence:
    N-6 His tag
  • Storage conditions:
    Store at −20 °C, stable for 6 months after receipt. Please minimize freeze−thaw cycles.
  • Enzyme name:
    Cyclin-Dependent Kinase 2
  • Purity:
    >95% as determined by reducing SDS-PAGE
  • Molecular weight:
    36.1 kD
  • Sequence:
    Met1-Leu298
  • Formulation:
    Supplied as a 0.2 µm filtered solution of 20 mM TrisHCl, 200 mM NaCl, 1 mM DTT, 40% Glycerol, pH 8.0. Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 ug/ml. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
  • Tested applications:
    Bioassay

 

 

Cyclin-dependent kinase 2 (CDK2) belongs to the cyclin-dependent kinase of Ser/Thr protein kinase. CDK2 acts as a catalytic subunit of the cyclin dependent kinase complex, whose activity is restricted to the G1-S phage of the cell cycle, it is essential for the G1/S transition. The kinase activity of CDK2 can be regulated by the association with a cyclin subunit, its phosphorylation state and CDK inhibitors. The activation of the CDK2/cyclin complex requires the phosphorylation of Thr160 and the dephosphorylation of Try14 and Tyr15. The inhibition of CDK2-cyclin complex can also be attributed to association with p27Kip1 and p21Waf1/Cip1. The activation of CDK2 has been shown to be necessary for apoptosis of quiescent cells, such as neurons, thymocytes and endothelial cells.

Fusion-Tag: N-6 His tag

This recombinant protein can be used for biological assays. For research use only.